18 Hrs
Source:
الاتحاد
WHO anticipates Ebola vaccine success
Helmann Laboratories in Singapore has announced the development of a candidate vaccine against a rare strain of the Ebola virus known as "Bundibugyo," which currently lacks an approved treatment or vaccine. According to the World Health Organization, the new vaccine is considered the most promising candidate to combat the outbreak in the Democratic Republic of the Congo. The vaccine is based on the rVSV platform, used in the Ervebo vaccine, and features the ability to be stored at room temperature, making distribution easier, especially in remote areas, and reducing costs. The development team is expediting clinical trial phases in preparation for its use in controlling the outbreak.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)